Sanyou Medical announced that the company plans to repurchase shares through centralized bidding, with a repurchase capital of 90 million yuan to 180 million yuan. The capital comes from its own capital and special loans. The repurchase price does not exceed 18.9 yuan/share, and the quantity is 4.7619 million shares to 9.523,800 shares, accounting for 1.30% to 2.60% of the total share capital. It is used for employee shareholding or equity incentives, and will be cancelled if not used up within three years. The repurchase period is within 6 months from the date the board of directors approves the plan. The company's actual controllers and others have no plans to reduce their holdings for the next 3 or 6 months. There are price and capital risks in this repurchase.

Sanyou Medical announced that the company plans to repurchase shares through centralized bidding, with a repurchase capital of 90 million yuan to 180 million yuan. The capital comes from its own capital and special loans. The repurchase price does not exceed 18.9 yuan/share, and the quantity is 4.7619 million shares to 9.523,800 shares, accounting for 1.30% to 2.60% of the total share capital. It is used for employee shareholding or equity incentives, and will be cancelled if not used up within three years. The repurchase period is within 6 months from the date the board of directors approves the plan. The company's actual controllers and others have no plans to reduce their holdings for the next 3 or 6 months. There are price and capital risks in this repurchase.